Cargando…

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis

BACKGROUND: Differences in pain between subtypes of multiple sclerosis are understudied. OBJECTIVE: To compare the prevalence of pain, and the association between pain and: (a) pain interference and (b) social participation in people with relapsing–remitting multiple sclerosis and progressive multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Dhruv, Bernstein, Charles N, Graff, Lesley A, Patten, Scott B, Bolton, James M, Fisk, John D, Hitchon, Carol, Marriott, James J, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359714/ https://www.ncbi.nlm.nih.gov/pubmed/37483527 http://dx.doi.org/10.1177/20552173231188469

Ejemplares similares

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
por: Almweisheer, Shaza, et al.
Publicado: (2023)

Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease
por: Kowalec, Kaarina, et al.
Publicado: (2022)

Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
por: Kowalec, Kaarina, et al.
Publicado: (2021)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?
por: Marrie, Ruth Ann
Publicado: (2017)

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease
por: Carney, Heather, et al.
Publicado: (2020)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Development of an indicator of smoking status for people with multiple sclerosis in administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis
por: van der Hiele, Karin, et al.
Publicado: (2015)

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease
por: Patel, Ronak, et al.
Publicado: (2023)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
por: Enns, Murray W., et al.
Publicado: (2018)

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
por: Marriott, James John, et al.
Publicado: (2023)

Risk knowledge of people with relapsing-remitting multiple sclerosis – Results of an international survey
por: Giordano, Andrea, et al.
Publicado: (2018)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines
por: Uddin, Md Nasir, et al.
Publicado: (2022)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f75bei4jvslfnlgqv4q6v3liij